UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (23) 23
science & technology (23) 23
male (15) 15
animals (10) 10
endocrinology & metabolism (10) 10
humans (10) 10
type 2 diabetes (10) 10
biological and medical sciences (9) 9
diabetes (9) 9
aged (8) 8
female (8) 8
middle aged (8) 8
rats (8) 8
diabetes mellitus, type 2 - drug therapy (7) 7
glucagon-like peptides - analogs & derivatives (7) 7
kidney diseases (7) 7
kidneys (7) 7
rats, sprague-dawley (7) 7
diabetes mellitus (6) 6
dulaglutide (6) 6
insulin (6) 6
risk factors (6) 6
treatment outcome (6) 6
cardiovascular system & cardiology (5) 5
epidermal growth factor receptors (5) 5
glomerular filtration rate (5) 5
glucagon-like peptides - therapeutic use (5) 5
human necessities (5) 5
hygiene (5) 5
hypertension (5) 5
hypoglycemic agents - therapeutic use (5) 5
immunoglobulin fc fragments - therapeutic use (5) 5
medical or veterinary science (5) 5
medical sciences (5) 5
patients (5) 5
preparations for medical, dental, or toilet purposes (5) 5
recombinant fusion proteins - therapeutic use (5) 5
specific therapeutic activity of chemical compounds ormedicinal preparations (5) 5
blood pressure - physiology (4) 4
cardiology. vascular system (4) 4
chronic kidney failure (4) 4
diabetes mellitus, type 2 - blood (4) 4
drug administration schedule (4) 4
fundamental and applied biological sciences. psychology (4) 4
glycosylated hemoglobin (4) 4
heme oxygenase (4) 4
heme oxygenase - metabolism (4) 4
kidney - metabolism (4) 4
physiology (4) 4
research (4) 4
rodents (4) 4
urology & nephrology (4) 4
abridged index medicus (3) 3
adult (3) 3
ang ii-dependent hypertension (3) 3
arterial hypertension. arterial hypotension (3) 3
blood and lymphatic vessels (3) 3
blood pressure (3) 3
carbon monoxide (3) 3
cardiac & cardiovascular systems (3) 3
creatinine (3) 3
diabetes mellitus, type 2 - complications (3) 3
diabetes therapy (3) 3
drug therapy (3) 3
enzyme inhibitors - pharmacology (3) 3
estimated glomerular filtration rate (3) 3
glp-1 receptor agonist (3) 3
glucagon-like peptide-1 receptor - agonists (3) 3
glucagon-like peptides - administration & dosage (3) 3
immunoglobulin fc fragments - administration & dosage (3) 3
immunohistochemistry (3) 3
insulin glargine (3) 3
peripheral vascular disease (3) 3
recombinant fusion proteins - administration & dosage (3) 3
vertebrates: urinary system (3) 3
2k1c (2) 2
adolescent (2) 2
angiotensin i - metabolism (2) 2
angiotensin ii (2) 2
angiotensin ii - pharmacology (2) 2
apoptosis (2) 2
arteries (2) 2
arterioles - physiology (2) 2
biomarkers - blood (2) 2
blood glucose - drug effects (2) 2
blood glucose - metabolism (2) 2
body weight (2) 2
body weight - drug effects (2) 2
brief report (2) 2
brief reports (2) 2
cardiology and cardiovascular medicine (2) 2
cardiovascular (2) 2
cardiovascular diseases (2) 2
clinical trials (2) 2
clinical trials, phase iii as topic (2) 2
complications and side effects (2) 2
confidence intervals (2) 2
cyclooxygenase (2) 2
diabetes mellitus, type 2 - metabolism (2) 2
disease models, animal (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cardiovascular diabetology, ISSN 1475-2840, 02/2016, Volume 15, Issue 1, pp. 38 - 38
Glucagon-like peptide-1 (GLP-1) | Type 2 diabetes | Cardiovascular events | Incretin | MACE | Meta-analysis | Cardiac & Cardiovascular Systems | Endocrinology & Metabolism | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prospective Studies | Recombinant Fusion Proteins - adverse effects | Glucagon-Like Peptides - administration & dosage | Humans | Middle Aged | Male | Immunoglobulin Fc Fragments - administration & dosage | Protective Factors | Clinical Trials, Phase III as Topic | Glucagon-Like Peptide-1 Receptor - metabolism | Hypoglycemic Agents - administration & dosage | Cardiovascular Diseases - mortality | Female | Glucagon-Like Peptides - analogs & derivatives | Diabetes Mellitus, Type 2 - complications | Immunoglobulin Fc Fragments - adverse effects | Recombinant Fusion Proteins - administration & dosage | Cardiovascular Diseases - diagnosis | Cardiovascular Diseases - etiology | Drug Administration Schedule | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Biomarkers - blood | Randomized Controlled Trials as Topic | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - diagnosis | Glucagon-Like Peptides - adverse effects | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - mortality | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Glucagon-Like Peptide-1 Receptor - agonists | Index Medicus
Journal Article
Journal Article
The American journal of gastroenterology, ISSN 0002-9270, 10/2016, Volume 111, p. S60
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 05/2018, Volume 67, Issue Supplement 1, p. 1557
Journal Article
The American journal of gastroenterology, ISSN 0002-9270, 10/2015, Volume 110, p. S205
Journal Article
Clinical therapeutics, ISSN 0149-2918, 08/2018, Volume 40, Issue 8, pp. 1396 - 1407
dulaglutide | glycosylated hemoglobin | estimated glomerular filtration rate | insulin glargine | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Recombinant Fusion Proteins - pharmacology | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Glomerular Filtration Rate - drug effects | Glucagon-Like Peptides - pharmacology | Renal Insufficiency - physiopathology | Female | Renal Insufficiency - complications | Immunoglobulin Fc Fragments - therapeutic use | Glucagon-Like Peptides - analogs & derivatives | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Insulin Glargine - therapeutic use | Treatment Outcome | Hypoglycemic Agents - pharmacology | Diabetes Mellitus, Type 2 - blood | Immunoglobulin Fc Fragments - pharmacology | Insulin Glargine - pharmacology | Creatinine - blood | Aged | Glucagon-Like Peptides - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Glycosylated hemoglobin | Medical records | Insulin | Analysis | Creatinine | Therapy | Statistical analysis | Calipers | Renal function | Epidermal growth factor receptors | Laboratories | Diabetes mellitus | Impairment | Hypoglycemia | Patients | Electronic medical records | Glomerular filtration rate | Laboratory tests | Reduction | Hemoglobin | Adults | Diabetes | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Electronic health records | Index Medicus
Journal Article
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 05/2018, Volume 67, Issue Supplement 1, p. 1066
Journal Article